Carolina Negrei

Carol Davila University of Medicine and Pharmacy

Papers

1

Total Citations

64

H-Index

1

About

Dr. Carolina Negrei is a pioneering researcher at the intersection of oncology, liquid biopsy, and artificial intelligence, with a primary focus on improving early detection and patient stratification in colorectal malignancies. Her landmark 2022 paper, "Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies," has garnered 64 citations, reflecting its significant impact on the field. In this work, Dr. Negrei demonstrates how combining minimally invasive liquid biopsy techniques with AI-driven analysis can identify molecular signatures of colorectal cancer—the second most common cancer worldwide—potentially enabling diagnosis at earlier, more treatable stages. Her research addresses a critical gap: while modern therapies have advanced, prognosis remains tightly linked to stage at diagnosis. By integrating computational tools with biological markers, she offers a modern, non-invasive approach to patient stratification. Dr. Negrei’s contributions are shaping the future of precision oncology, making her a key voice in the movement toward smarter, earlier cancer detection. Her work continues to inspire researchers seeking to harness technology for tangible clinical breakthroughs.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
64 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Carol Davila University of Medicine and Pharmacy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago